Announcement on Cooperative Investment with Private Fund
Filed with SSE · · 6 pages · Chinese
Beijing Sun-Novo Pharmaceutical Research Co. Ltd. on 6ix
Earlier from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Progress in Litigation Involved by the Company
- Announcement on Terminating the Issuance of Shares and Convertible Corporate Bonds to Purchase Assets and Raising Supporting Funds and Related Party Transactions, and the Withdrawal of Application Documents
- Announcement on Voluntary Disclosure on the Acceptance of Clinical Trial Application for ABA001 Injection
- Announcement on Litigation Results of the Company
Later from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Clinical Trials of BTP4327
- Announcement on Voluntary Disclosure of External Investment
- Announcement on the Self-Inspection Report on Insider Trading During the Self-Inspection Period by Persons Aware of Material Non-public Information Related to the Termination of Issuance of Shares and Convertible Corporate Bonds to Acquire Assets, Raising Supporting Funds, and Related Party Transactions
- Announcement on Postponing Term Change of the Board of Directors and Resignation upon Term Expiration of Partial Independent Directors
- Announcement on Voluntary Disclosure of Obtaining Notice of Approval for Drug Clinical Trial of ABA001 Injection
Follow Beijing Sun-Novo Pharmaceutical Research into a list and get an email when it puts out news.
Follow Beijing Sun-Novo Pharmaceutical Research